Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
Massimo Pieri, Marco Ciotti, Marzia Nuccetelli, Marco Alfonso Perrone, Maria Teresa Caliò, Maria Stella Lia, Marilena Minieri, Sergio Bernardini
Topics & Concepts
ProcalcitoninMedicineSerum amyloid ABiomarkerInternal medicineGastroenterologySerum Amyloid A ProteinAcute-phase proteinC-reactive proteinSeverity of illnessCoronavirus disease 2019 (COVID-19)Receiver operating characteristicClinical significanceDiseaseInflammationSepsisInfectious disease (medical specialty)ChemistryBiochemistryPancreatitis Pathology and TreatmentCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research